Genomics pioneer J. Craig Venter launched Diploid Genomics, an AI‑driven advanced genomics analytics company, with Healthier Capital as a cofounder and sole external investor. The new company intends to apply large‑scale analytics and AI to human genomics datasets to derive clinical and research insights, positioning itself at the intersection of advanced sequencing, federated data and machine learning. The launch brings a high‑profile founder into the growing market for genomic analytics and underscores continued investor interest in AI‑enabled interpretation platforms. Observers will watch for product positioning (clinical vs. research), data partnerships, and regulatory strategy for clinical‑grade outputs that could touch diagnostics and precision‑medicine workflows.